The role of immunotherapy in the treatment of lip squamous cell carcinoma: A series of six cases and a review of the current literature
Background: Squamous cell carcinoma (SCC) of the lip is a distinct subtype of oral cavity SCC, accounting for about 10–20 % of all oral cavity cancers. According to National Comprehensive Cancer Network (NCCN) guidelines, treatment consists of surgical resection with adjuvant radiotherapy or chemora...
Saved in:
Main Authors: | Ido Amir, Nir Tsur, Itamar Averbuch, Gideon Bachar, Noga Kurman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-06-01
|
Series: | Oral Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003716 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transformative advancements in immune checkpoint inhibitor therapy for Oropharyngeal Squamous Cell Carcinoma (OPSCC)
by: Iadalin Ryntathiang, et al.
Published: (2024-09-01) -
Efficacy and safety of PD-1 inhibitors as second-line treatment for advanced squamous esophageal cancer: a systematic review and network meta-analysis with a focus on PD-L1 expression levels
by: Fei Yang, et al.
Published: (2025-01-01) -
A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma
by: Daniel S. Alicea, MS, et al.
Published: (2025-03-01) -
Surgical margins of the oral cavity: is 5 mm really necessary?
by: James Fowler, et al.
Published: (2022-10-01) -
A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
by: Lin Li, et al.
Published: (2025-01-01)